COPD

Biotech Blogs

Chiesi on Sustainability in Asthma and COPD R&D
Life Science Podcast

Sustainability in Asthma and COPD Drug Development with Chiesi’s Diego Ardigò — Episode 259
Biotech News

Tozorakimab Scores Double Win in Phase III COPD Trials
Biotech Blogs

Designing Clinical Trials to Address Asthma and COPD Flare-Ups
Life Science Podcast

Pioneering Biosensors for Continuous Medical Monitoring with Profusa CEO Dr. Ben Hwang — Episode 236
Biotech Blogs

Top 5 Best-Selling Respiratory Disease Drugs to Watch in 2025
Biotech Blogs

Top 15 Most Innovative Pharma & Biotech Companies of 2025, According to Fast Company
Blogs

COPD Awareness Month 2024: Get Active and Lace-Up for Lungs
Approvals News

Verona’s COPD Drug Ohtuvayre (ensifentrine) Gets FDA Nod

Going Beyond ATS/ERS 2019 Guidelines for Your Respiratory Clinical Trials

April 17, 2024
Biotech News

Bayer and Partners HealthCare Open a Joint Lab for Lung Disease Research
Clinical Trial News

Will GSK’s Trelegy Make Its Mark in Asthma?
Life Science News

Mylan’s Generic Advair Breathes New Life into Asthma Market
Approvals News

COPD Maintenance Therapy Yupelri Gets FDA Win for Mylan and Theravance Biopharma
Life Science News

American Lung Association Highlights Health Benefits of Vaccines During National Immunization Awareness Month
Biotech News

FDA Isn’t So Sure About GSK’s COPD Drug Nucala